US Patent Issued to Janssen Pharmaceutica on Dec. 23 for "Monoacylglycerol lipase modulators for use in autism spectrum disorders" (California, Pennsylvania, New Jersey Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,502,378, issued on Dec. 23, was assigned to Janssen Pharmaceutica NV (Beerse, Belgium).

"Monoacylglycerol lipase modulators for use in autism spectrum disorders" was invented by Bashkim Kadriu (La Jolla, Calif.), John A. Moyer (New Hope, Pa.), Gahan J. Pandina (East Windsor, N.J.) and Ryan Michael Wyatt (Carlsbad, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to certain uses and methods of use of 3.1.0 and 4.1.0 azabicycle compounds of Formula (I), wherein X, Y, R1, R2a, and R2b are defined herein, and pharmaceutical compositions containing them, in the treatment of autism spectrum disorder, including Asperger's syndrome."...